Top 10 Pharmaceutical Companies in India in 2025
India’s pharmaceutical industry is on the rise, with its top companies becoming key players on the global stage. Behind their success lies a blend of...
Tag : pharmaceuticals
Morepen Labs Shares Zoom 18% over Clearing USFDA Inspection
On Monday, shares of Morepen Laboratories, a smallcap pharma company that manufactures Burnol, surged up to 18% during intra-day trades following an announcement to the...
Lupin Pharma Signs Licensing Pact with Japan-based I’rom Group
On Thursday, Drug maker Lupin informed that it had inked a licensing pact with Japan-based I’rom Group Co for a product used, inter alia, in...
India’s Exports Rise to $418 Billion in FY22
India’s exports reached a record high of $418 billion in FY22 on higher shipments of petroleum products, engineering goods, gem and jewellery and chemicals, according...
Modi Plans Technology Mainstay of Making India Self-Reliant
On Wednesday, PM Narendra Modi Wednesday called the technology a medium for empowering people and said it is the mainstay of making India self-reliant. He...
Abbott India Ltd. had blockbuster FNO debut on Friday’s Trading session. What’s Ahead?
Abbott India Ltd NSE :ABBOTINDIA BSE :500488 Sector : Pharmaceuticals About Company: Abbott India is engaged in the business of manufacturing, selling, distribution and marketing of Pharmaceuticals. Daily Chart...
Exports Jump to $32.21 Billion in May Up 67%
India’s exports grew by 67.39 per cent to USD 32.21 billion in May driven by healthy growth in sectors such as engineering, pharmaceuticals, petroleum products,...
Mobiles, TVs, to be Available on Amazon, Flipkart from April 20
Mobile phones, televisions, refrigerators, laptops and stationary items will be allowed to be sold through e-commerce platforms like Amazon, Flipkart and Snapdeal from April...
Govt Puts A 30 Per Cent Trade Margin Cap On Anti-Cancer Drugs
The governmental body Department of Pharmaceuticals taking a big decision towards anti-cancer drugs has announced to puts a cap on trade margin of 30 per...
SEBI Examining The Complaint Against Sun Pharma’s Dilip Shanghvi
SEBI has announced that it is examining the whistleblower complaint against Dilip Shanghvi, CEO and Managing Director of Sun Pharmaceutical Industries. SEBI Chairman Ajay Tyagi...